Stonebridge Capital Management Inc. Cuts Stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)


Share on StockTwits

Stonebridge Capital Management Inc. lowered its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 0.4% during the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 76,809 shares of the medical instruments supplier’s stock after selling 300 shares during the period. DENTSPLY SIRONA makes up about 1.9% of Stonebridge Capital Management Inc.’s portfolio, making the stock its 19th biggest position. Stonebridge Capital Management Inc.’s holdings in DENTSPLY SIRONA were worth $4,901,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Sei Investments Co. increased its stake in shares of DENTSPLY SIRONA by 1.2% during the fourth quarter. Sei Investments Co. now owns 370,233 shares of the medical instruments supplier’s stock valued at $19,390,000 after buying an additional 4,214 shares during the period. Exchange Traded Concepts LLC increased its stake in shares of DENTSPLY SIRONA by 855.0% during the fourth quarter. Exchange Traded Concepts LLC now owns 1,060 shares of the medical instruments supplier’s stock valued at $56,000 after buying an additional 949 shares during the period. Public Employees Retirement System of Ohio grew its stake in shares of DENTSPLY SIRONA by 6.4% during the third quarter. Public Employees Retirement System of Ohio now owns 88,719 shares of the medical instruments supplier’s stock worth $3,880,000 after acquiring an additional 5,329 shares during the last quarter. Raymond James Trust N.A. grew its stake in shares of DENTSPLY SIRONA by 8.6% during the fourth quarter. Raymond James Trust N.A. now owns 9,033 shares of the medical instruments supplier’s stock worth $473,000 after acquiring an additional 712 shares during the last quarter. Finally, Aviva PLC grew its stake in shares of DENTSPLY SIRONA by 2.5% during the fourth quarter. Aviva PLC now owns 72,371 shares of the medical instruments supplier’s stock worth $3,789,000 after acquiring an additional 1,754 shares during the last quarter. Hedge funds and other institutional investors own 96.00% of the company’s stock.

In other DENTSPLY SIRONA news, Director Gregory T. Lucier purchased 5,000 shares of the firm’s stock in a transaction dated Thursday, March 4th. The shares were acquired at an average price of $58.95 per share, with a total value of $294,750.00. Following the purchase, the director now directly owns 13,850 shares in the company, valued at approximately $816,457.50. The purchase was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Eric Brandt sold 7,600 shares of the company’s stock in a transaction on Wednesday, March 17th. The shares were sold at an average price of $63.21, for a total value of $480,396.00. Following the completion of the transaction, the director now directly owns 38,131 shares in the company, valued at approximately $2,410,260.51. The disclosure for this sale can be found here. 0.53% of the stock is currently owned by insiders.

A number of research firms recently commented on XRAY. Robert W. Baird lifted their target price on DENTSPLY SIRONA from $62.00 to $71.00 and gave the stock an “outperform” rating in a report on Tuesday, March 2nd. HC Wainwright reaffirmed a “neutral” rating and set a $60.00 target price (up previously from $55.00) on shares of DENTSPLY SIRONA in a report on Tuesday, March 2nd. Stifel Nicolaus downgraded DENTSPLY SIRONA from a “buy” rating to a “hold” rating and set a $52.00 target price for the company. in a report on Friday, December 18th. Barclays lifted their target price on DENTSPLY SIRONA from $50.00 to $55.00 and gave the stock an “underweight” rating in a report on Tuesday, March 2nd. Finally, Barrington Research raised DENTSPLY SIRONA from a “market perform” rating to an “outperform” rating and set a $71.00 target price for the company in a report on Monday, March 8th. One analyst has rated the stock with a sell rating, six have given a hold rating and seven have given a buy rating to the stock. DENTSPLY SIRONA has a consensus rating of “Hold” and a consensus target price of $54.69.

Shares of XRAY stock traded down $0.80 during trading hours on Thursday, hitting $63.14. 24,660 shares of the company’s stock were exchanged, compared to its average volume of 1,640,007. The company has a quick ratio of 2.38, a current ratio of 3.10 and a debt-to-equity ratio of 0.47. The firm has a market cap of $13.83 billion, a P/E ratio of -278.00, a P/E/G ratio of 5.06 and a beta of 0.98. The firm has a 50 day moving average of $59.65 and a two-hundred day moving average of $53.26. DENTSPLY SIRONA Inc. has a fifty-two week low of $36.12 and a fifty-two week high of $65.09.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its earnings results on Sunday, February 28th. The medical instruments supplier reported $0.87 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.64 by $0.23. The business had revenue of $1.08 billion during the quarter, compared to the consensus estimate of $997.38 million. DENTSPLY SIRONA had a positive return on equity of 7.13% and a negative net margin of 1.40%. The business’s quarterly revenue was down 2.6% on a year-over-year basis. During the same period in the prior year, the company posted $0.73 EPS. On average, equities analysts forecast that DENTSPLY SIRONA Inc. will post 1.12 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Friday, April 9th. Investors of record on Friday, March 26th will be given a dividend of $0.10 per share. This represents a $0.40 annualized dividend and a dividend yield of 0.63%. The ex-dividend date of this dividend is Thursday, March 25th. DENTSPLY SIRONA’s payout ratio is 16.33%.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc designs, develops, manufactures, distributes, and sells various dental products and technologies primarily for professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression and restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.

Featured Article: How Do Mutual Funds Work?

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.